This article evaluates the welfare implications of a public procurement program, where the Ecuadorian government procures medicines used for cancer treatment and distributes it to patients for free with the aim to benefit the poor. Using a unique dataset on Ecuador’s pharmaceutical market, we estimate a structural model of demand and supply, and focus on two research questions related to this program.
Supplementary notes can be added here, including code and math.